Blastomycosis

 

 Buy Article Permissions and Reprints

Blastomycosis is an endemic fungal infection predominantly seen in the south central and mid-western United States and portions of Canada. The disorder is caused by Blastomyces dermatitidis, a dimorphic organism usually acquired through inhalation of aerosolized conidia. Most acutely infected patients are asymptomatic or develop a self-limited respiratory illness. Chronic pneumonia is the dominant clinical manifestation of blastomycosis, although extrapulmonary disease is common, usually involving skin and subcutaneous tissue, bones and joints, the prostate gland, and the central nervous system (CNS). Chronic blastomycosis should always be treated with systemic antifungal therapy, and oral itraconazole is the drug of choice for mild to moderate forms of the disease. Severe manifestations, including adult respiratory distress syndrome, CNS involvement, and disease in severely immunocompromised hosts require primary therapy with an amphotericin B formulation. There are no routine measures to prevent blastomycosis, although there is promising experimental data involving the use of a live, attenuated vaccine.

REFERENCES

• 1 Kwon-Chung KJ, Bennett JE Blastomycosis. In: Medical Mycology . Philadelphia; Lea & Febiger 1992: 248-279
  Google Scholar
• 2 Furcolow M L, Busey J F, Menges R W, Chick E W. Prevalence and incidence studies of human and canine blastomycosis.  Am J Epidemiol. 1970;  92 121-131
  PubMedGoogle Scholar
• 3 Busey J F. Blastomycosis: a review of 198 collected cases in Veterans Administration hospitals.  Am Rev Respir Dis. 1964;  89 659-672
  PubMedGoogle Scholar
• 4 Furcolow M L, Chick E W, Busey J F, Menges R W. Prevalence and incidence studies of human and canine blastomycosis.  Am Rev Respir Dis. 1970;  102 60-67
  PubMedGoogle Scholar
• 5 Crampton T L, Light R B, Berg G M et al.. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals.  Clin Infect Dis. 2002;  34 1310-1316
  CrossrefPubMedGoogle Scholar
• 6 De Groote M A, Bjerke R, Smith H, Rhodes III L V. Expanding epidemiology of blastomycosis: clinical features and investigation of 2 cases in Colorado.  Clin Infect Dis. 2000;  30 582-584
  CrossrefPubMedGoogle Scholar
• 7 Gilchrist T C. Protozoan dermatitidis.  J Cutan Genitourin Dis. 1894;  12 496
  PubMedGoogle Scholar
• 8 Gilchrist T C, Stokes W R. A case of pseudolupus caused by Blastomyces .  J Exp Med. 1898;  3 53-78
  CrossrefPubMedGoogle Scholar
• 9 Schwarz J, Baum G L. Blastomycosis.  Am J Clin Pathol. 1951;  21 999-1029
  CrossrefPubMedGoogle Scholar
• 10 Klein B S, Vergeront J M, Weeks R J et al.. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin.  N Engl J Med. 1986;  314 529-534
  CrossrefPubMedGoogle Scholar
• 11 Baumgardner D J, Paretsky D P. The in vitro isolation of Blastomyces dermatitidis from a woodpile in north central Wisconsin, USA.  Med Mycol. 1999;  37 163-168
  CrossrefPubMedGoogle Scholar
• 12 Centers for Disease Control and Prevention . Blastomycosis-Wisconsin, 1986-1995.  MMWR Morb Mortal Wkly Rep. 1996;  45 601-603
  PubMedGoogle Scholar
• 13 Vasquez J E, Mehta J B, Agrawal R, Sarubbi F A. Blastomycosis in northeast Tennessee.  Chest. 1998;  114 436-443
  CrossrefPubMedGoogle Scholar
• 14 Bradsher R W, Chapman S W, Pappas P G. Blastomycosis.  Infect Dis Clin North Am. 2003;  17 21-40
  CrossrefPubMedGoogle Scholar
• 15 Bernstein S, Richardson S. Inoculation blastomycosis.  Can Med Assoc J. 2001;  164 1664-1665
  PubMedGoogle Scholar
• 16 Larson D M, Eckman M R, Alber R L, Goldschmidt V G. Primary cutaneous (inoculation) blastomycosis: an occupational hazard to pathologists.  Am J Clin Pathol. 1983;  79 253-255
  PubMedGoogle Scholar
• 17 Gnann J W, Bressler G S, Bodet C A, Avent C K. Human blastomycosis after a dog bite.  Ann Intern Med. 1983;  98 48-49
  PubMedGoogle Scholar
• 18 Craig M W, Davey W N, Green R A. Conjugal blastomycosis.  Am Rev Respir Dis. 1970;  102 86-90
  PubMedGoogle Scholar
• 19 Watts E A, Gard P D, Tuthill S W. First reported case of intrauterine transmission of blastomycosis.  Pediatr Infect Dis. 1983;  2 308-310
  CrossrefPubMedGoogle Scholar
• 20 Schutze G E, Hickerson S L, Fortin E M et al.. Blastomycosis in children.  Clin Infect Dis. 1996;  22 496-502
  PubMedGoogle Scholar
• 21 Hansen J E, Simmons D H. An urban epidemic of North American blastomycosis.  Am Rev Respir Dis. 1977;  115 1063-1066
  PubMedGoogle Scholar
• 22 Tosh F E, Hammerman K J, Weeks R J, Sarosi G A. A common source of epidemic of North American blastomycosis.  Am Rev Respir Dis. 1974;  109 525-529
  PubMedGoogle Scholar
• 23 Smith Jr J G, Harris J S, Conant N F, Smith D T. An epidemic of North American blastomycosis.  JAMA. 1955;  158 641-645
  PubMedGoogle Scholar
• 24 Klein B S, Vergeront J M, Disalvo A F, Kaufman L, Davis J. Two outbreaks of blastomycosis along rivers in Wisconsin.  Am Rev Respir Dis. 1987;  136 1333-1338
  CrossrefPubMedGoogle Scholar
• 25 Armstrong C W, Jenkins S R, Kaufman L, Kerkering T M, Rouse B S, Miller G B. Common-source outbreak of blastomycosis in hunters and their dogs.  J Infect Dis. 1987;  155 568-570
  CrossrefPubMedGoogle Scholar
• 26 Vaaler A D, Bradsher R W, Davies S F. Evidence of subclinical blastomycosis in forestry workers in northern Minnesota and northern Wisconsin.  Am J Med. 1990;  89 470-476
  CrossrefPubMedGoogle Scholar
• 27 Sarosi G A, Davies S F. Blastomycosis.  Am Rev Respir Dis. 1979;  120 911-938
  PubMedGoogle Scholar
• 28 Bradsher R W, Martin M R, Wilkes T D, Waltman C, Bolyard K. Unusual manifestations of blastolycosis: ten case summaries.  Infect Med. 1990;  7 10-19
  PubMedGoogle Scholar
• 29 Baum G L, Lerner P I. Primary pulmonary blastomycosis: a laboratory-acquired infection.  Ann Intern Med. 1970;  73 263-265
  PubMedGoogle Scholar
• 30 Sarosi G A, Davies S F, Phillips J R. Self-limited blastomycosis: a report of 39 cases.  Semin Respir Infect. 1986;  1 40-44
  PubMedGoogle Scholar
• 31 Recht L D, Phillips J R, Eckman M R, Sarosi G A. Self-limited blastomycosis: a report of thirteen cases.  Am Rev Respir Dis. 1979;  120 1109-1112
  PubMedGoogle Scholar
• 32 Sarosi G A, Hammerman K J, Tosh F E, Kronenberg R S. Clinical features of acute pulmonary blastomycosis.  N Engl J Med. 1974;  290 540-543
  PubMedGoogle Scholar
• 33 Abernathy R S. Clinical manifestations of pulmonary blastomycosis.  Ann Intern Med. 1959;  51 707-727
  PubMedGoogle Scholar
• 34 Brown L R, Swensen S J, Van Scoy R E, Prakash U BS, Coles D T, Colby T V. Roentgenologic features of pulmonary blastomycosis.  Mayo Clin Proc. 1991;  66 29-38
  CrossrefPubMedGoogle Scholar
• 35 Patel R G, Patel B, Petrini M F, Carter R R, Griffith J. Clinical presentation, radiographic findings, and diagnostic methods of pulmonary blastomycosis: a review of 100 consecutive cases.  South Med J. 1999;  92 289-295
  CrossrefPubMedGoogle Scholar
• 36 Rabinowitz J G, Busch J, Buttram W R. Pulmonary manifestations of blastomycosis.  Radiology. 1976;  120 25-32
  PubMedGoogle Scholar
• 37 Kinasewitz G T, Penn R L, George R B. The spectrum and significance of pleural disease in blastomycosis.  Chest. 1984;  86 580-584
  PubMedGoogle Scholar
• 38 Evans M E, Haynes J B, Atkinson J B, Delvaux T C, Kaiser A B. Blastomyces dermatitidis and the adult respiratory distress syndrome: case reports and review of the literature.  Am Rev Respir Dis. 1982;  126 1099-1102
  PubMedGoogle Scholar
• 39 Griffith J E, Campbell G D. Acute military blastomycosis presenting as fulminating respiratory failure.  Chest. 1979;  75 630-632
  CrossrefPubMedGoogle Scholar
• 40 Meyer K C, McManus E J, Make D G. Overwhelming pulmonary blastomycosis associated with the adult respiratory distress syndrome.  N Engl J Med. 1993;  329 1231-1236
  CrossrefPubMedGoogle Scholar
• 41 Lockridge R S, Glauser F L. Adult respiratory distress syndrome secondary to diffuse pulmonary blastomycosis.  South Med J. 1979;  72 235-236
  PubMedGoogle Scholar
• 42 Mundey K, Varkey B, VanRuiswyk J, Yang F, Schapira R M. Acute respiratory distress syndrome from blastomycosis: a case report.  WMJ. 2001;  100 40-42
  PubMedGoogle Scholar
• 43 Lemos L B, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature.  Ann Diagn Pathol. 2001;  5 1-9
  CrossrefPubMedGoogle Scholar
• 44 Stelling C B, Woodring J H, Rehn S R, Hopper D W, Noble R C. Miliary pulmonary blastomycosis.  Radiology. 1984;  150 7-13
  PubMedGoogle Scholar
• 45 Renston J P, Morgan J, DiMarco A F. Disseminated military blastomycosis leading to acute respiratory failure in an urban setting.  Chest. 1992;  101 1463-1465
  PubMedGoogle Scholar
• 46 Isotalo P A, Ford J C, Veinot J P. Miliary blastomycosis developing in an immunocompromised host with chronic lymphocytic leukaemia.  Pathol. 2002;  34 293-295
  PubMedGoogle Scholar
• 47 Chapman S W. Blastomyces dermatitidis . In: Mandell GL, Bennett JE, Dolin R Principles and Practice of Infectious Diseases. New York; Churchill Livingstone 2000: 2733-2746
  Google Scholar
• 48 Schwarz J, Salfelder K. Blastomycosis: a review of 152 cases.  Curr Top Pathol. 1977;  65 165-200
  PubMedGoogle Scholar
• 49 Pappas P G, Dismukes W E. Blastomycosis: Gilchrist's disease revisited.  Curr Clin Top Infect Dis. 2002;  22 61-77
  PubMedGoogle Scholar
• 50 Bayer A S, Scott V J, Guze L B. Fungal arthritis, IV: Blastomycotic arthritis.  Semin Arthritis Rheum. 1979;  9 145-151
  PubMedGoogle Scholar
• 51 Saccente M, Abernathy R S, Pappas P G, Shah H R, Bradsher R W. Vertebral blastomycosis with paravertebral abscess: report of eight cases and review of the literature.  Clin Infect Dis. 1998;  26 413-418
  CrossrefPubMedGoogle Scholar
• 52 Eikenberg H U, Amin H U, Lich R. Blastomycosis of the genitourinary tract.  J Urol. 1975;  113 650-652
  PubMedGoogle Scholar
• 53 Beuchner H A, Clawson C M. Blastomycosis of the central nervous system.  Am Rev Respir Dis. 1966;  95 820-826
  PubMedGoogle Scholar
• 54 Gonyea E F. The spectrum of primary blastomycetic meningitis: a review of central nervous system blastomycosis.  Ann Neurol. 1978;  3 26-39
  CrossrefPubMedGoogle Scholar
• 55 Friedman J A, Wijdicks E FM, Fulgham J R, Wright A J. Meningoencephalitis due to Blastomyces dermatitidis: case report and literature review.  Mayo Clin Proc. 2000;  75 403-408
  CrossrefPubMedGoogle Scholar
• 56 Roos K L, Bryan J P, Maggio W W, Jane J A, Scheld W M. Intracranial blastomycoma.  Medicine (Baltimore). 1987;  66 224-235
  PubMedGoogle Scholar
• 57 Harley W B, Lomis M, Haas D W. Marked polymorphonuclear pleocytosis due to blastomycotic meningitis: case report and review.  Clin Infect Dis. 1994;  18 816-818
  CrossrefPubMedGoogle Scholar
• 58 Ebeo C T, Olive K, Byrd R P, Mirle G, Roy T M, Mehta J B. Blastomycosis of the vocal folds with life-threatening upper airway obstruction: a case report.  Ear Nose Throat J. 2002;  81 852-855
  PubMedGoogle Scholar
• 59 Lopez R, Mason J O, Parker J S, Pappas P G. Intraocular blastomycosis: case report and review.  Clin Infect Dis. 1994;  18 805-807
  PubMedGoogle Scholar
• 60 Pappas P G, Pottage J C, Powderly W G et al.. Blastomycosis in patients with acquired immunodeficiency syndrome.  Ann Intern Med. 1992;  116 847-853
  CrossrefPubMedGoogle Scholar
• 61 Laskey W K, Sarosi G A. Blastomycosis in children.  Pediatrics. 1980;  65 111-114
  PubMedGoogle Scholar
• 62 Palmer P E, McFadden S W. Blastomycosis: report of an unusual case.  N Engl J Med. 1976;  279 979-983
  PubMedGoogle Scholar
• 63 Cummins R E, Romero R C, Mancini A J. Disseminated North American blastomycosis in an adolescent male: a delay in diagnosis.  Pediatrics. 1998;  102 977-979
  CrossrefPubMedGoogle Scholar
• 64 Pappas P G, Threlkeld M G, Bedsole G D, Cleveland K O, Gelfand M S, Dismukes W E. Blastomycosis in immunocompromised patients.  Medicine. 1993;  72 311-325
  CrossrefPubMedGoogle Scholar
• 65 Pappas P G. Blastomycosis in immunocompromised patients.  Semin Respir Infect. 1997;  12 243-251
  PubMedGoogle Scholar
• 66 Srinath L, Ahkee S, Huang A, Raff M J, Ramirez A. Acute military blastomycosis in an AIDS patient.  J Kentuk Med Assoc. 1994;  92 450-452
  PubMedGoogle Scholar
• 67 Harding C V. Blastomycosis and opportunistic infections in patients with acquired immunodeficiency syndrome: an autopsy study.  Arch Pathol Lab Med. 1991;  115 1133-1136
  PubMedGoogle Scholar
• 68 Nelson M R, Barton S E, Hawkins D A, Gazzard B G. Blastomycosis in an HIV positive male in the UK.  Int J STD AIDS. 1993;  4 176-177
  PubMedGoogle Scholar
• 69 Tan G, Kaufman L, Peterson E M, de la Maza L M. Disseminated atypical blastomycosis in two patients with AIDS.  Clin Infect Dis. 1993;  16 107-111
  PubMedGoogle Scholar
• 70 Herd A M, Greenfield S B, Thompson W S, Brunham R C. Miliary blastomycosis and HIV infection.  Can Med Assoc J. 1990;  143 1329-1330
  PubMedGoogle Scholar
• 71 Pradinaud R, Sainte-Marie D, Clity E. Premier cas guyanais de blastomycose avec intense focalisation nasale chez une patiente infectee par le V.I.H  Nouv Dermatol. 1991;  10 480-482
  PubMedGoogle Scholar
• 72 Witzig R S, Hoadley D J, Greer D L, Abriola K P, Hernandez R L. Blastomycosis and human immunodeficiency virus: three new cases and review.  South Med J. 1994;  87 715-719
  CrossrefPubMedGoogle Scholar
• 73 Kitchen L W, Clark R A, Hoadley D J, Wisniewski T L, Janney F A, Greer D L. Concurrent pulmonary Blastomyces dermatitidis and Mycobacterium tuberculosis infection in an HIV-1 seropositive man.  J Infect Dis. 1989;  160 911-912
  PubMedGoogle Scholar
• 74 Cohen L M, Golitz L E, Wilson M L. Widespread papules and nodules in a Ugandan man with acquired immunodeficiency syndrome.  Arch Dermatol. 1996;  132 821-826
  CrossrefPubMedGoogle Scholar
• 75 Klein B S, Kuritsky J N, Chappell W A et al.. Comparison of enzyme immunoassay, immunodiffusion, and complement fixation in detecting antibody to the A antigen in Blastomyces dermatitidis .  Am Rev Respir Dis. 1986;  133 144-148
  PubMedGoogle Scholar
• 76 Lo C Y, Notenboom R H. A new enzyme immunoassay specific for blastomycosis.  Am Rev Respir Dis. 1990;  141 84-88
  PubMedGoogle Scholar
• 77 Chapman S E, Bradsher R W, Campbell G D, Pappas P G, Kauffman C A. Practice guidelines for the management of patients with blastomycosis.  Clin Infect Dis. 2000;  30 679-683
  CrossrefPubMedGoogle Scholar
• 78 National Institute of Allergy and Infectious Diseases Mycoses Study Group . Treatment of blastomycosis and histoplasmosis with ketoconazole: results of a prospective randomized clinical trial.  Ann Intern Med. 1985;  103 861-872
  PubMedGoogle Scholar
• 79 Bradsher R W, Rice D C, Abernathy R S. Ketoconazole therapy for endemic blastomycosis.  Ann Intern Med. 1985;  103 872-879
  PubMedGoogle Scholar
• 80 Dismukes W E, Bradsher R W, Cloud G C et al.. Itraconazole therapy for blastomycosis and histoplasmosis.  Am J Med. 1992;  93 489-497
  CrossrefPubMedGoogle Scholar
• 81 Bradsher R W. Blastomycosis.  Clin Infect Dis. 1992;  14(suppl 1) S82-S90
  CrossrefPubMedGoogle Scholar
• 82 Pitrak D L, Andersen B R. Cerebral blastomycoma after ketoconazole therapy for respiratory tract blastomycosis.  Am J Med. 1989;  86 713-714
  CrossrefPubMedGoogle Scholar
• 83 Yancey R W, Perlino C A, Kaufman L. Asymptomatic blastomycosis of the central nervous system with progression in patients given ketoconazole therapy: a report of two cases.  J Infect Dis. 1991;  164 807-810
  PubMedGoogle Scholar
• 84 Cook P P. Amphotericin B lipid complex for the treatment of recurrent blastomycosis of the brain in a patient previously treated with itraconazole.  South Med J. 2001;  94 548-549
  PubMedGoogle Scholar
• 85 Pappas P G, Bradsher R W, Chapman S W et al.. and the National Institute of Allergy and Infectious Diseases Mycoses Study Group . Treatment of blastomycosis with fluconazole: a pilot study.  Clin Infect Dis. 1995;  20 267-271
  CrossrefPubMedGoogle Scholar
• 86 Pappas P G, Bradsher R W, Kauffman C A et al.. and the National Institute of Allergy and Infectious Diseases Mycoses Study Group . Treatment of blastomycosis with higher doses of fluconazole.  Clin Infect Dis. 1997;  25 200-205
  CrossrefPubMedGoogle Scholar
• 87 Sugar A M, Liu X P. Efficacy of voriconazole in treatment of murine pulmonary blastomycosis.  Antimicrob Agents Chemother. 2001;  45 601-604
  CrossrefPubMedGoogle Scholar
• 88 Hoffman H L, Ernst E J, Klepser M E. Novel triazole antifungal agents.  Expert Opin Investig Drugs. 2000;  9 593-605
  CrossrefPubMedGoogle Scholar
• 89 Ernst E J. Investigational antifungal agents.  Pharmacotherapy. 2001;  21(8 pt 2) 165S-174S
  CrossrefPubMedGoogle Scholar
• 90 Perfect J R, Marr K A, Walsh T J et al.. Voriconazole treatment for less-common, emerging, or refractory fungal infections.  Clin Infect Dis. 2003;  36 1122-1131
  CrossrefPubMedGoogle Scholar
• 91 Lockwood W R, Allison Jr F, Batson B E, Busey J F. The treatment of North American blastomycosis: ten years experience.  Am Rev Respir Dis. 1969;  100 314-320
  PubMedGoogle Scholar
• 92 Busey J F. Blastomycosis: a comparative study of 2-hydroxystilbamidine and amphotericin B therapy.  Am Rev Respir Dis. 1972;  105 812-818
  PubMedGoogle Scholar
• 93 Wuthrich M, Filutowicz I, Klein B S. Mutation of the WI-1 gene yields an attenuated Blastomyces dermatitidis strain that induces host resistance.  J Clin Invest. 2000;  106 1381-1389
  PubMedGoogle Scholar

Peter G PappasM.D. 

Division of Infectious Diseases, University of Alabama at Birmingham

1900 University Blvd., 229 THT

Birmingham, AL 35294-0006

Email: pappas@uab.edu